GlassScriptPhysician profile
Tyler Shipley
NPI 1518601244
$1,681.71
in general payments reported to CMS, 2019-2025
9 companies · $569 in 2025
The $569 reported for 2025 was more than what 81% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $390 · 2024: $723 · 2025: $569.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,664 · Travel and Lodging: $18.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,663.53 |
| Travel and Lodging | $18.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $754.35 | 2023-2025 | Accolade Sr, Lithovue, Advance Xp |
| Photocure INC | $239.47 | 2024-2025 | Cysview |
| Janssen Scientific Affairs, LLC | $148.69 | 2024-2025 | Erleada, Akeega, Balversa |
| Calyxo, INC. | $144.98 | 2025 | Cvac Aspiration System |
| Olympus America INC. | $140.47 | 2024 | Itind System |
| Sumitomo Pharma America, INC. | $109.44 | 2023 | Gemtesa |
| Progenics Pharmaceuticals, INC. | $52.85 | 2024 | |
| Teleflex LLC | $50.78 | 2025 | Barrigel |
| Myriad Genetic Laboratories, INC. | $40.68 | 2023 | Prolaris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Shipley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.